| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3348218 | Diagnostic Microbiology and Infectious Disease | 2009 | 4 Pages |
Abstract
We compared 41 patients who received colistimethate with 41 who received polymyxin B for the treatment of serious infections caused by carbapenem-resistant Acinetobacter spp. and found both polymyxins have similar efficacy and toxicity.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Maura S. Oliveira, Gladys V.B. Prado, Silvia F. Costa, Renato S. Grinbaum, Anna S. Levin,